UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Drive Wealth Management LLC

Drive Wealth Management LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,068 shares of the healthcare conglomerate’s stock after purchasing an additional 135 shares during the quarter. Drive Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,552,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the third quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC purchased a new position in UnitedHealth Group in the third quarter worth approximately $32,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the third quarter worth $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $532.26 on Monday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock’s 50 day moving average is $541.04 and its two-hundred day moving average is $564.34. The firm has a market capitalization of $489.83 billion, a PE ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on UNH shares. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.